Profiles

Keywords
Last Name
Institution

Michael Bradaric

TitleAssociate Professor
InstitutionRush University, Rush Medical College
DepartmentAnatomy and Cell Biology
Address
vCardDownload vCard

    Collapse Overview 
    Collapse overview
    My Scopus ID is 35490007100.

    Research Areas:
    Ovarian cancer: molecular pathogenesis, tumor microenvironment, immune cell/cancer communication, drug targets for metastasis, drug repurposing. Drug discovery from marine sources.

    My Faculty Profile at Rush University Medical Center:
    https://www.rushu.rush.edu/faculty/michael-bradaric-phd

    My NCBI Bibliography:
    https://www.ncbi.nlm.nih.gov/myncbi/browse/collection/50159123/?sort=date&direction=descending

    My Scopus:
    https://www.scopus.com/authid/detail.uri?authorId=35490007100

    Education:
    PhD, pharmacology, Rush University


    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Puglisi MP, Bradaric MJ, Pontikis J, Cabai J, Weyna T, Tednes P, Schretzman R, Rickert K, Cao Z, Andrei D. Novel primary amine diazeniumdiolates-Chemical and biological characterization. Drug Dev Res. 2018 May; 79(3):136-143. PMID: 29719056.
      View in: PubMed
    2. Lengyel E, Litchfield LM, Mitra AK, Nieman KM, Mukherjee A, Zhang Y, Johnson A, Bradaric M, Lee W, Romero IL. Metformin inhibits ovarian cancer growth and increases sensitivity to paclitaxel in mouse models. Am J Obstet Gynecol. 2015 Apr; 212(4):479.e1-479.e10. PMID: 25446664.
      View in: PubMed
    3. Habis M, Wroblewski K, Bradaric M, Ismail N, Yamada SD, Litchfield L, Lengyel E, Romero IL. Statin therapy is associated with improved survival in patients with non-serous-papillary epithelial ovarian cancer: a retrospective cohort analysis. PLoS One. 2014; 9(8):e104521. PMID: 25118694.
      View in: PubMed
    4. Barua A, Bradaric MJ, Bitterman P, Abramowicz JS, Sharma S, Basu S, Lopez H, Bahr JM. Dietary supplementation of Ashwagandha (Withania somnifera, Dunal) enhances NK cell function in ovarian tumors in the laying hen model of spontaneous ovarian cancer. Am J Reprod Immunol. 2013 Dec; 70(6):538-50. PMID: 24188693.
      View in: PubMed
    5. Bradaric MJ, Penumatsa K, Barua A, Edassery SL, Yu Y, Abramowicz JS, Bahr JM, Luborsky JL. Immune cells in the normal ovary and spontaneous ovarian tumors in the laying hen (Gallus domesticus) model of human ovarian cancer. PLoS One. 2013; 8(9):e74147. PMID: 24040191.
      View in: PubMed
    6. Barua A, Bitterman P, Bahr JM, Basu S, Sheiner E, Bradaric MJ, Hales DB, Luborsky JL, Abramowicz JS. Contrast-enhanced sonography depicts spontaneous ovarian cancer at early stages in a preclinical animal model. J Ultrasound Med. 2011 Mar; 30(3):333-45. PMID: 21357555.
      View in: PubMed
    7. Bradaric MJ, Barua A, Penumatsa K, Yi Y, Edassery SL, Sharma S, Abramowicz JS, Bahr JM, Luborsky JL. Sphingosine-1 phosphate receptor (S1p1), a critical receptor controlling human lymphocyte trafficking, is expressed in hen and human ovaries and ovarian tumors. J Ovarian Res. 2011 Feb 28; 4(1):4. PMID: 21356044.
      View in: PubMed
    8. Penumatsa K, Edassery SL, Barua A, Bradaric MJ, Luborsky JL. Differential expression of aldehyde dehydrogenase 1a1 (ALDH1) in normal ovary and serous ovarian tumors. J Ovarian Res. 2010 Dec 22; 3:28. PMID: 21176222.
      View in: PubMed
    9. Barua A, Bitterman P, Bahr JM, Bradaric MJ, Hales DB, Luborsky JL, Abramowicz JS. Detection of tumor-associated neoangiogenesis by Doppler ultrasonography during early-stage ovarian cancer in laying hens: a preclinical model of human spontaneous ovarian cancer. J Ultrasound Med. 2010 Feb; 29(2):173-82. PMID: 20103787.
      View in: PubMed
    10. Barua A, Bitterman P, Abramowicz JS, Dirks AL, Bahr JM, Hales DB, Bradaric MJ, Edassery SL, Rotmensch J, Luborsky JL. Histopathology of ovarian tumors in laying hens: a preclinical model of human ovarian cancer. Int J Gynecol Cancer. 2009 May; 19(4):531-9. PMID: 19509547.
      View in: PubMed
    11. Barua A, Edassery SL, Bitterman P, Abramowicz JS, Dirks AL, Bahr JM, Hales DB, Bradaric MJ, Luborsky JL. Prevalence of antitumor antibodies in laying hen model of human ovarian cancer. Int J Gynecol Cancer. 2009 May; 19(4):500-7. PMID: 19509543.
      View in: PubMed
    12. Barua A, Abramowicz JS, Bahr JM, Bitterman P, Dirks A, Holub KA, Sheiner E, Bradaric MJ, Edassery SL, Luborsky JL. Detection of ovarian tumors in chicken by sonography: a step toward early diagnosis in humans? J Ultrasound Med. 2007 Jul; 26(7):909-19. PMID: 17592054.
      View in: PubMed
    13. Barua A, Bradaric MJ, Kebede T, Espionosa S, Edassery SL, Bitterman P, Rotmensch J, Luborsky JL. Anti-tumor and anti-ovarian autoantibodies in women with ovarian cancer. Am J Reprod Immunol. 2007 Apr; 57(4):243-9. PMID: 17362385.
      View in: PubMed
    Bradaric's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    See all (77) concept(s)
    _
    Co-Authors Expand Description
    See all (1) people
    _
    Similar People Expand Description
    See all (60) people
    _
    Same Department Expand Description
    Search Department